The U.S. authorities have selected five companies that are likely to produce vaccine against the new coronavirus. These are the vaccines of Moderna, Merck, Johnson & Johnson, Pfizer and the vaccine of the British-Swedish pharmaceutical company AstraZeneca in cooperation with Oxford University. Moderna, Johnson & Johnson and AstraZeneca have already received $2.2 billion in federal funding to support their vaccine development programs.